Nikhil Lalwani Insider Trades & Stock Holdings

PRESIDENT & CEO · ANI Pharmaceuticals, Inc. · Latest filing Oct 15, 2026

Nikhil Lalwani, PRESIDENT & CEO at ANI Pharmaceuticals, Inc. has 1 Form 4 trade on file since Oct 15, 2026. Open-market activity: 0 purchases ($0) and 1 sale ($388.21K), net -$388.21K. Latest filing: disposed of 5.40K shares of $ANIP on Oct 15, 2026 at $71.89.

Trades on file

1

Open-market bought

$0

Open-market sold

$388.21K

Net open-market

-$388.21K

Shares held ($ANIP)

333.69K

Latest filing

Oct 15, 2026

Shares held by Nikhil Lalwani

• $ANIP333.69K sh

Shares owned after the most recent Form 4 for each company.

All insider trades by Nikhil Lalwani

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Oct 15, 2026	$ANIP	Sell (Open-market sale) 10b5-1	5.40K	$71.89	$388.21K	333.69K	-1.59%				PRESIDENT & CEO	SEC	Read

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Nikhil Lalwani traded

• $ANIP

Frequently asked questions

Has Nikhil Lalwani been buying or selling stock?

Nikhil Lalwani has 0 open-market purchases and 1 open-market sale on file, net -$388.21K. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Nikhil Lalwani's latest insider trade?

disposed of 5.40K shares of $ANIP on Oct 15, 2026 at $71.89.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.